BOLT — Bolt Therapeutics Inc

Ownership history in Vivo Capital, LLC  ·  20 quarters on record

This page tracks every 13F SEC filing in which Vivo Capital, LLC reported a position in Bolt Therapeutics Inc (BOLT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.48% (2021 Q1)
Avg. % of fund
0.8%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 72,414 -103,650 -58.9% 0.03% $396K $5.47
2025 Q3 UNCHANGED 176,064 — 0% 0.08% $937K $5.32
2025 Q2 REDUCED 176,064 -3,345,227 -95.0% 0.10% $986K $5.77
2025 Q1 UNCHANGED 3,521,291 — 0% 0.19% $1.4M $8.00
16 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BOLT price (monthly, adj. close)

Other funds also holding BOLT

As of 2025 Q4 — sorted by position size

Nan Fung Group Holdings Ltd 3Y 0.29% Pivotal bioVenture Partners Investment Advisor LLC 3Y 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.1% PFIZER INC 0.07% Board of Trustees of The Leland Stanford Junior University 3Y 7Y 0.04% Sofinnova Investments, Inc. 3Y 7Y 0.03% Shay Capital LLC 3Y 0.01% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0%
← Back to Vivo Capital, LLC Holdings